InsidersTradesSigma
Discover the detailed record of transactions filed by BORMANN-KENNEDY BARBARA-JEAN ANNE, Director. Director active across 1 companies, notably Xeris Biopharma Holdings, Inc.. Cumulatively, 1 disclosures have been published. The latest transaction was disclosed on 8 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Barbara-Jean Anne Bormann-Kennedy is a Director at Xeris Biopharma Holdings, Inc. She plays a vital role in corporate governance and strategic decision-making. As a board member, she helps guide Xeris Biopharma's growth initiatives. Her experience in the biopharmaceutical sector is an asset for the company.